Cargando…

IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells

Interferon induced transmembrane proteins (IFITMs) found in vertebrates restrict infections by specific viruses. IFITM3 is known to be essential for restriction of influenza virus infections in both mice and humans. Vertebrate IFITMs are hypothesized to have derived from a horizontal gene transfer f...

Descripción completa

Detalles Bibliográficos
Autores principales: Melvin, William J., McMichael, Temet M., Chesarino, Nicholas M., Hach, Jocelyn C., Yount, Jacob S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488726/
https://www.ncbi.nlm.nih.gov/pubmed/26075508
http://dx.doi.org/10.3390/v7062759
_version_ 1782379211675140096
author Melvin, William J.
McMichael, Temet M.
Chesarino, Nicholas M.
Hach, Jocelyn C.
Yount, Jacob S.
author_facet Melvin, William J.
McMichael, Temet M.
Chesarino, Nicholas M.
Hach, Jocelyn C.
Yount, Jacob S.
author_sort Melvin, William J.
collection PubMed
description Interferon induced transmembrane proteins (IFITMs) found in vertebrates restrict infections by specific viruses. IFITM3 is known to be essential for restriction of influenza virus infections in both mice and humans. Vertebrate IFITMs are hypothesized to have derived from a horizontal gene transfer from bacteria to a primitive unicellular eukaryote. Since bacterial IFITMs share minimal amino acid identity with human IFITM3, we hypothesized that examination of bacterial IFITMs in human cells would provide insight into the essential characteristics necessary for antiviral activity of IFITMs. We examined IFITMs from Mycobacterium avium and Mycobacterium abscessus for potential antiviral activity. Both of these IFITMs conferred a moderate level of resistance to influenza virus in human cells, identifying them as functional homologues of IFITM3. Analysis of sequence elements shared by bacterial IFITMs and IFITM3 identified two hydrophobic domains, putative S-palmitoylation sites, and conserved phenylalanine residues associated with IFITM3 interactions, which are all necessary for IFITM3 antiviral activity. We observed that, like IFITM3, bacterial IFITMs were S-palmitoylated, albeit to a lesser degree. We also demonstrated the ability of a bacterial IFITM to co-immunoprecipitate with IFITM3 suggesting formation of a complex, and also visualized strong co-localization of bacterial IFITMs with IFITM3. However, the mycobacterial IFITMs lack the endocytic-targeting motif conserved in vertebrate IFITM3. As such, these bacterial proteins, when expressed alone, had diminished colocalization with cathepsin B-positive endolysosomal compartments that are the primary site of IFITM3-dependent influenza virus restriction. Though the precise evolutionary origin of vertebrate IFITMs is not known, our results support a model whereby transfer of a bacterial IFITM gene to eukaryotic cells may have provided a selective advantage against viral infection that was refined through the course of vertebrate evolution to include more robust signals for S-palmitoylation and localization to sites of endocytic virus trafficking.
format Online
Article
Text
id pubmed-4488726
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44887262015-07-02 IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells Melvin, William J. McMichael, Temet M. Chesarino, Nicholas M. Hach, Jocelyn C. Yount, Jacob S. Viruses Article Interferon induced transmembrane proteins (IFITMs) found in vertebrates restrict infections by specific viruses. IFITM3 is known to be essential for restriction of influenza virus infections in both mice and humans. Vertebrate IFITMs are hypothesized to have derived from a horizontal gene transfer from bacteria to a primitive unicellular eukaryote. Since bacterial IFITMs share minimal amino acid identity with human IFITM3, we hypothesized that examination of bacterial IFITMs in human cells would provide insight into the essential characteristics necessary for antiviral activity of IFITMs. We examined IFITMs from Mycobacterium avium and Mycobacterium abscessus for potential antiviral activity. Both of these IFITMs conferred a moderate level of resistance to influenza virus in human cells, identifying them as functional homologues of IFITM3. Analysis of sequence elements shared by bacterial IFITMs and IFITM3 identified two hydrophobic domains, putative S-palmitoylation sites, and conserved phenylalanine residues associated with IFITM3 interactions, which are all necessary for IFITM3 antiviral activity. We observed that, like IFITM3, bacterial IFITMs were S-palmitoylated, albeit to a lesser degree. We also demonstrated the ability of a bacterial IFITM to co-immunoprecipitate with IFITM3 suggesting formation of a complex, and also visualized strong co-localization of bacterial IFITMs with IFITM3. However, the mycobacterial IFITMs lack the endocytic-targeting motif conserved in vertebrate IFITM3. As such, these bacterial proteins, when expressed alone, had diminished colocalization with cathepsin B-positive endolysosomal compartments that are the primary site of IFITM3-dependent influenza virus restriction. Though the precise evolutionary origin of vertebrate IFITMs is not known, our results support a model whereby transfer of a bacterial IFITM gene to eukaryotic cells may have provided a selective advantage against viral infection that was refined through the course of vertebrate evolution to include more robust signals for S-palmitoylation and localization to sites of endocytic virus trafficking. MDPI 2015-06-12 /pmc/articles/PMC4488726/ /pubmed/26075508 http://dx.doi.org/10.3390/v7062759 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Melvin, William J.
McMichael, Temet M.
Chesarino, Nicholas M.
Hach, Jocelyn C.
Yount, Jacob S.
IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
title IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
title_full IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
title_fullStr IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
title_full_unstemmed IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
title_short IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells
title_sort ifitms from mycobacteria confer resistance to influenza virus when expressed in human cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488726/
https://www.ncbi.nlm.nih.gov/pubmed/26075508
http://dx.doi.org/10.3390/v7062759
work_keys_str_mv AT melvinwilliamj ifitmsfrommycobacteriaconferresistancetoinfluenzaviruswhenexpressedinhumancells
AT mcmichaeltemetm ifitmsfrommycobacteriaconferresistancetoinfluenzaviruswhenexpressedinhumancells
AT chesarinonicholasm ifitmsfrommycobacteriaconferresistancetoinfluenzaviruswhenexpressedinhumancells
AT hachjocelync ifitmsfrommycobacteriaconferresistancetoinfluenzaviruswhenexpressedinhumancells
AT yountjacobs ifitmsfrommycobacteriaconferresistancetoinfluenzaviruswhenexpressedinhumancells